Allogene Therapeutics, Inc.

ALLO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$1.84-2.13%

2026-08-03

Financials

Valuation Metrics

Allogene Therapeutics, Inc.'s Market Cap is $635M. At end of 2025 it was $302M. Ranked #2704 of 3,112 in US market (top 87%), #1155 of 1,445 on NASDAQ (top 80%), #214 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 80%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$635M	US#2,704/3,112 Sec#214/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-174M	US—/3,112 Sec—/269
Total Assets	$396M	US#2,832/3,112 Sec#188/269
Net Assets	$279M	US#2,586/3,112 Sec#165/269
Value
P/B	2.28x	US#1,350/3,112 Sec#61/269
FCF Yield	-17.25%	US—/3,112 Sec—/269
Profitability
ROE	-62.31%	US#2,782/3,112 Sec#193/269
ROA	-43.88%	US#2,940/3,112 Sec#201/269
Revenue Growth	-100.00%	US#2,948/3,112 Sec#190/269
Financial Health
Debt Ratio	41.98%	US#477/3,112 Sec#132/269
Total Debt	$81M	US#2,434/3,112 Sec#125/269
FCF	$-110M	US#2,607/3,112 Sec#157/269
Cash	$30M	US#2,762/3,112 Sec#251/269
Current Ratio	9.65x	US#260/3,112 Sec#81/269
Performance
1Y Return	70.37%	US#517/3,112 Sec#103/269
1M Return	-11.54%	US#2,676/3,112 Sec#182/269
From 52W High	-58.74%	US#2,923/3,112 Sec#238/269
1Y MDD	-45.75%	US#2,231/3,112 Sec#170/269
Trading
Volume	6,947,069 shares	US#263/3,112 Sec#18/269
Trading Value	$13M	US#2,219/3,112 Sec#174/269
Per Share
EPS	$-0.87	US—/3,112 Sec—/269
BPS	$1.33	US#2,580/3,112 Sec#193/269